ChromaDex (CDXC) 10-Q 14 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Apr. 04, 2015	13-May-15
Document And Entity Information
Entity Registrant Name	ChromaDex Corp.
Entity Central Index Key	1386570
Document Type	10-Q
Document Period End Date	4-Apr-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-1
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		107,421,275
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Apr. 04, 2015	Jan. 03, 2015
Current Assets
Cash	$3,215,839	$3,964,750
Trade receivables, less allowance for doubtful accounts and returns, April 4, 2015 $51,000; January 3, 2015 $38,000	2,234,453	1,906,709
Inventories	3,231,696	3,734,341
Prepaid expenses and other assets	374,350	292,891
Total current assets	9,056,338	9,898,691
Leasehold Improvements and Equipment, net	1,579,994	1,264,660
Other Noncurrent Assets
Deposits	57,560	57,435
Intangible assets, net	290,937	296,061
Total other noncurrent assets	348,497	353,496
Total assets	10,984,829	11,516,847
Current Liabilities
Accounts payable	2,640,950	3,451,608
Accrued expenses	1,003,579	853,685
Current maturities of loan payable	452,672	223,358
Current maturities of capital lease obligations	207,413	148,278
Customer deposits and other	393,352	234,435
Deferred rent, current	73,942	69,456
Total current liabilities	4,771,908	4,980,820
Loan payable, less current maturities, net	1,794,747	1,977,113
Capital lease obligations, less current maturities	610,738	423,015
Deferred rent, less current	118,651	137,508
Total Liabilities	7,296,044	7,518,456
Stockholders' Equity
Common stock, $.001 par value; authorized 150,000,000 shares; issued and outstanding April 4, 2015 105,987,058 and January 3, 2015 105,271,058 shares	105,987	105,271
Additional paid-in capital	44,132,635	43,417,442
Accumulated deficit	-40,549,837	-39,524,322
Total stockholders' equity	3,688,785	3,998,391
Total liabilities and stockholders' equity	$10,984,829	$11,516,847

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Statement of Financial Position [Abstract]
Trade receivables, less allowance for doubtful accounts and returns	$51,000	$38,000
Common Stock, Par Value Per Share	$0.00	$0.00
Common Stock, Shares Authorized	150,000,000	150,000,000
Common Stock, Shares, Issued	105,987,058	105,271,058
Common Stock, Shares, Outstanding	105,987,058	105,271,058

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014
Income Statement [Abstract]
Sales, net	$5,260,971	$3,074,138
Cost of sales	3,333,347	2,089,130
Gross profit	1,927,624	985,008
Operating expenses:
Sales and marketing	585,777	464,567
General and administrative	2,247,931	2,337,663
Loss from investment in affiliate		21,543
Operating expenses	2,833,708	2,823,773
Operating loss	-906,084	-1,838,765
Nonoperating income (expense):
Interest income	718	640
Interest expense	-120,149	-9,891
Nonoperating expenses	-119,431	-9,251
Net loss	($1,025,515)	($1,848,016)
Basic and Diluted loss per common share	($0.01)	($0.02)
Basic and Diluted weighted average common shares outstanding	107,198,597	106,076,361

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Jan. 03, 2015	$105,271	$43,417,442	($39,524,322)	$3,998,391
Beginning Balance, Shares at Jan. 03, 2015	105,271,058
Share-based compensation, Shares	216,000
Share-based compensation, Amount	216	715,693		715,909
Vested restricted stock, shares	500,000
Vested restricted stock, Amount	500	-500
Net loss			-1,025,515	-1,025,515
Ending Balance, Amount at Apr. 04, 2015	$105,987	$44,132,635	($40,549,837)	$3,688,785
Ending Balance, Shares at Apr. 04, 2015	105,987,058

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014
Cash Flows From Operating Activities
Net loss	($1,025,515)	($1,848,016)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	66,902	50,919
Amortization of intangibles	10,124	7,633
Share-based compensation expense	715,909	999,661
Allowance for doubtful trade receivables	13,526	7,110
Gain on sale of equipment		-103
Loss from disposal of equipment	17,475
Loss from investment in affiliate		21,543
Non-cash financing costs	46,948
Changes in operating assets and liabilities:
Trade receivables	-341,270	-835,758
Other receivable		215,000
Inventories	502,645	-288,652
Prepaid expenses and other assets	-81,584	-123,367
Accounts payable	-810,658	481,159
Accrued expenses	149,894	74,894
Customer deposits and other	158,917	-157,020
Deferred rent	-14,371	-9,788
Net cash used in operating activities	-591,058	-1,404,785
Cash Flows From Investing Activities
Purchases of leasehold improvements and equipment	-95,778	-14,623
Purchases of intangible assets	-5,000	-5,000
Proceeds from sale of equipment		1,356
Proceeds from investment in affiliate		1,092,500
Net cash (used in) provided by investing activities	-100,778	1,074,233
Cash Flows From Financing Activities
Proceeds from exercise of stock options		27,100
Principal payments on capital leases	-57,075	-33,346
Net cash used in financing activities	-57,075	-6,246
Net decrease in cash	-748,911	-336,798
Cash Beginning of Period	3,964,750	2,261,336
Cash Ending of Period	3,215,839	1,924,538
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	73,202	9,891
Supplemental Schedule of Noncash Investing Activity
Capital lease obligation incurred for the purchase of equipment	303,933
Supplemental Schedule of Noncash Share-based Compensation
Changes in prepaid expenses associated with share-based compensation		$49,718

Interim_Financial_Statements

Interim Financial Statements	3 Months Ended
	Apr. 04, 2015
Interim Financial Statements
Note 1. Interim Financial Statements	The accompanying financial statements of ChromaDex Corporation (the “Company”) and its wholly owned subsidiaries, ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. include all adjustments, consisting of normal recurring adjustments and accruals, that, in the opinion of the management of the Company, are necessary for a fair presentation of the Company’s financial position as of April 4, 2015 and results of operations and cash flows for the three months ended April 4, 2015 and March 29, 2014. These unaudited interim financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the year ended January 3, 2015 appearing in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on March 19, 2015. Operating results for the three months ended April 4, 2015 are not necessarily indicative of the results to be achieved for the full year ending on January 2, 2016.  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.
	The balance sheet at January 3, 2015 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

Nature_of_Business_and_Liquidi

Nature of Business and Liquidity	3 Months Ended
	Apr. 04, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Note 2. Nature of Business and Liquidity	Nature of business:  The Company is a natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its business model that utilizes its wholly owned business units, including ingredient technologies, catalog of natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting services.  The Company provides science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries.
	Liquidity:  The Company has incurred a loss from operations of approximately $906,000 and a net loss of approximately $1,026,000 for the three-month period ended April 4, 2015.  As of April 4, 2015, the cash and cash equivalents totaled approximately $3,216,000.
	The Company has approximately $2,500,000 of available credit on its term loan that can be drawn down by July 31, 2015.  While we anticipate that our current cash and cash equivalents on hand, cash generated from operations and the available credit on the term loan that can be drawn down will be sufficient to meet our projected operating plans through at least May 15, 2016, we may require additional funds, either through additional equity or debt financings or collaborative agreements or from other sources. We have no commitments to obtain such additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all. If adequate financing is not available, the Company will further delay, postpone or terminate product and service expansion and curtail certain selling, general and administrative operations.  The inability to raise additional financing may have a material adverse effect on the future performance of the Company.

Significant_Accounting_Policie

Significant Accounting Policies	3 Months Ended
	Apr. 04, 2015
Accounting Policies [Abstract]
Note 3. Significant Accounting Policies	Basis of presentation:  The financial statements and accompanying notes have been prepared on a consolidated basis and reflect the consolidated financial position of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated from these financial statements. The Company’s fiscal year ends on the Saturday closest to December 31.    Every fifth or sixth fiscal year, the inclusion of an extra week occurs due to the Company’s floating year-end date. The fiscal year 2014 ended on January 3, 2015 consisted of 53 weeks. The fiscal year 2015 ending on January 2, 2016 will include the normal 52 weeks.
	Changes in accounting principle: In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.  The amendments in this ASU require that debt issuance costs related to a debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs have not changed.  For public business entities, the amendments are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years.  Early adoption of the amendments is permitted for financial statements that have not been previously issued.
	The Company early adopted the amendments in this ASU effective as of April 4, 2015.  As of April 4, 2015 and January 3, 2015, the Company had unamortized debt issuance costs of $80,455 and $91,361, respectively.  The Company had previously presented the debt issuance costs as other noncurrent assets in its consolidated balance sheet as of January 3, 2015 in the Company’s Annual Report on Form 10-K filed with the Commission on March 19, 2015.  The early adoption has resulted in adjustments to the Company’s consolidated balance sheet as of January 3, 2015, by reclassifying the debt issuance costs as a direct deduction from the carrying amount of the debt liability.  Below are the effects of the change on the consolidated balance sheet as of January 3, 2015.
	ChromaDex Corporation and Subsidiaries
	Condensed Consolidated Balance Sheet
	3-Jan-15
		Previously		Adjustments			As Adjusted
		Reported
	Assets
	Current Assets	$	9,898,691	$	-		$	9,898,691
	Leasehold Improvements and Equipment, net		1,264,660		-			1,264,660
	Other Noncurrent Assets		444,857		(91,361	)		353,496
	Total assets	$	11,608,208	$	(91,361	)	$	11,516,847
	Liabilities and Stockholders' Equity
	Current Liabilities	$	4,980,820	$	-		$	4,980,820
	Loan payable, less current maturities, net		2,068,474		(91,361	)		1,977,113
	Capital lease obligations, less current maturities		423,015		-			423,015
	Deferred rent, less current		137,508		-			137,508
	Total liabilities		7,609,817		(91,361	)		7,518,456
	Total stockholders' equity		3,998,391		-			3,998,391
	Total liabilities and stockholders' equity	$	11,608,208	$	(91,361	)	$	11,516,847
	Inventories:  Inventories are comprised of raw materials, work-in-process and finished goods.  They are stated at the lower of cost, determined by the first-in, first-out method (FIFO) method, or market.  Labor and overhead has been added to inventory that was manufactured or characterized by the Company.  The amounts of major classes of inventory as of April 4, 2015 and January 3, 2015 are as follows:
		4-Apr-15		3-Jan-15
	Reference standards	$	1,718,313	$	1,760,305
	Bulk ingredients		1,956,383		2,298,036
			3,674,696		4,058,341
	Less valuation allowance		443,000		324,000
		$	3,231,696	$	3,734,341

Loss_Per_Share_Applicable_to_C

Loss Per Share Applicable to Common Stockholders	3 Months Ended
	Apr. 04, 2015
Loss Per Share Applicable To Common Stockholders
Note 4. Loss Per Share Applicable to Common Stockholders	The following table sets forth the computations of loss per share amounts applicable to common stockholders for the three months ended April 4, 2015 and March 29, 2014:
		Three Months Ended
		April 4,			March 29,
		2015			2014
	Net loss	$	(1,025,515	)	$	(1,848,016	)
	Basic and diluted loss per common share	$	(0.01	)	$	(0.02	)
	Weighted average common shares outstanding (1):		107,198,597			106,076,361
	Potentially dilutive securities (2):
	Stock options		14,146,969			13,326,655
	Warrants		469,020			-
	Convertible Debt		773,395			-
	(1) Includes 1,554,088 and 1,542,088 weighted average nonvested shares of restricted stock for the three months ended April 4, 2015 and March 29, 2014, respectively, which are participating securities that feature voting and dividend rights.
	(2) Excluded from the computation of loss per share as their impact is antidilutive.

Leasehold_Improvements_and_Equ

Leasehold Improvements and Equipment	3 Months Ended
	Apr. 04, 2015
Leasehold Improvements And Equipment
Note 6. Leasehold Improvements and Equipment	Leasehold improvements and equipment consisted of the following:
		April 4,		3-Jan-15
		2015
	Laboratory equipment	$	3,514,733	$	3,151,748
	Leasehold improvements		495,240		495,240
	Computer equipment		333,567		329,737
	Furniture and fixtures		13,039		13,039
	Office equipment		7,877		7,877
	Construction in progress		28,737		68,141
			4,393,193		4,065,782
	Less accumulated depreciation		2,813,199		2,801,122
		$	1,579,994	$	1,264,660
	Depreciation expense on leasehold improvements and equipment included in the consolidated statement of operations for the three months ended April 4, 2015 and March 29, 2014 was approximately $67,000 and $51,000, respectively.

Loan_Payable

Loan Payable	3 Months Ended
	Apr. 04, 2015
Debt Disclosure [Abstract]
Loan Payable
	Loan payable as of April 4, 2015 consists of the following:
	Principal amount payable for following years ending December
	2015	$	223,358
	2016		867,247
	2017		1,035,995
	2018		373,400
	Total principal payments		2,500,000
	Accrued end of term charge		20,425
	Total loan payable		2,520,425
	Less unamortized debt issuance costs and debt discount		273,006
	Less current portion		452,672
	Loan payable – long term	$	1,794,747
	The total interest expenses related to the term loan, including cash interest payments, the amortizations of debt issuance costs and debt discount, and the accrual of the end of term charge were approximately $106,000 for the three months ended April 4, 2015.  For the three months ended March 29, 2014, the Company did not have any interest expense related to loan payable as the Company did not have any outstanding balance.

ShareBased_Compensation

Share-Based Compensation	3 Months Ended
	Apr. 04, 2015
Share-based Compensation
Share-Based Compensation
	7A. Employee Share-Based Compensation
	Stock Option Plans
	The fair value of the Company’s stock options was estimated at the date of grant using the Black-Scholes option pricing model.  The table below outlines the weighted average assumptions for options granted to employees during the three months ended April 4, 2015.
	Three Months Ended April 4, 2015
	Expected volatility	75%
	Expected dividends	0.00%
	Expected term	6.1 years
	Risk-free rate	1.68%
	The weighted average grant date fair value of options granted during the three months ended April 4, 2015 was $0.85.
	Service Period Based Stock Options
	The majority of options granted by the Company feature service conditions.  Accordingly, these options vest ratably over specified periods of approximately 3 to 5 years following the date of grant.
	The following table summarizes our stock option activity during the three months ended April 4, 2015:
						Weighted Average				Aggregate
										Intrinsic
			Number of			Exercise		Remaining		Value
			Shares			Price		Contractual
								Term
	Outstanding at January 3, 2015			12,723,601		$	1.13		7
	Options Granted			185,000			1.29		10
	Options Classification from Employee to Non-Employee			(451,738	)		0.88
	Options Exercised			-			-
	Options Forfeited			(12,083	)		1.14
	Outstanding at April 4, 2015			12,444,780		$	1.14		6.75	$	5,237,000
	Exercisable at April 4, 2015			9,608,011		$	1.14		6.21	$	3,981,000
	The aggregate intrinsic values in the table above are based on the Company’s closing stock price of $1.55 on the last day of business for the period ended April 4, 2015.
	Certain employees who were previously classified as employees under the share-based compensation plan have been reclassified to non-employees during the three months ended April 4, 2015 as they became consultants.  There was no impact on accounting as the options were fully vested.
	As of April 4, 2015, there was approximately $1,434,000 of total unrecognized compensation expense expected to be recognized over a weighted average period of 2.39 years.
	Restricted Stock
	Restricted stock awards granted by the Company to employees have vesting conditions that are unique to each award.
	The following table summarizes activity of restricted stock awards granted to employees at April 4, 2015 and changes during the three months then ended:
			Shares			Weighted Average
						Award-Date
						Fair Value
	Unvested shares at January 3, 2015			1,590,000		$	1.18
	Granted			-			-
	Vested			(500,000	)		1.41
	Forfeited			-			-
	Unvested shares at April 4, 2015			1,090,000		$	1.08
	Expected to Vest as of April 4, 2015			1,090,000		$	1.08
	Employee Option and Restricted Stock Compensation
	The Company recognized compensation expense of approximately $378,000 and $950,000 in general and administrative expenses in the statement of operations for the three months ended April 4, 2015 and March 29, 2014, respectively.
	7B. Non-Employee Share-Based Compensation
	Stock Option Plans
	The following table summarizes activity of stock options granted to non-employees at April 4, 2015 and changes during the three months then ended:
						Weighted Average
			Number of			Exercise		Remaining		Aggregate
			Shares			Price		Contractual		Intrinsic
								Term		Value
	Outstanding at January 3, 2015			1,050,451		$	1.35		5.46
	Options Granted			-			-
	Options Classification from Employee to Non-Employee			451,738			0.88
	Options Exercised			-			-
	Options Forfeited			-			-
	Outstanding at April 4, 2015			1,502,189		$	1.21		6.07	$	506,000
	Exercisable at April 4, 2015			1,434,689		$	1.21		5.91	$	485,000
	The aggregate intrinsic values in the table above are based on the Company’s closing stock price of $1.55 on the last day of business for the period ended April 4, 2015.
	As of April 4, 2015, there was approximately $67,000 of total unrecognized compensation expense expected to be recognized over a weighted average period of 1.44 years.
	Stock Awards
	On January 27, 2015, the Company awarded 350,000 shares of the Company’s common stock to non-employees.  210,000 of these shares were fully vested and non-forfeitable and the remaining 140,000 shares can be surrendered and forfeited if the Company delivers termination notices for any reason prior to May 28, 2015.  The fair value of the awards for the fully vested 210,000 shares was $180,600, and was measured based on the trading price of the Company’s stock on the date of grant.  This fair value was expensed immediately on the date of grant.  The expense for the remaining forfeitable 140,000 shares are recognized ratably through May 28, 2015.  The fair values will be remeasured until the shares are fully vested.
	As of April 4, 2015, there was approximately $98,000 of total unrecognized compensation expense related to the stock awards to non-employees.  That cost is expected to be recognized over a period of approximately 2 months as of April 4, 2015.
	Restricted Stock
	Restricted stock awards granted by the Company to non-employees generally feature time vesting service conditions, specified in the respective service agreements.  Restricted stock awards issued to non-employees are accounted for at current fair value through the vesting period.  The fair value of vested non-employee restricted shares awarded during the three months ended April 4, 2015 was approximately $7,000, which represents the market value of the Company’s common stock on respective vesting dates charged to expense.
	The following table summarizes activity of restricted stock awards issued to non-employees at April 4, 2015 and changes during the three months then ended:
					Weighted Average
		Shares			Fair Value
Unvested shares at January 3, 2015			76,000		$	0.9
Granted			-			-
Vested			(6,000	)		1.23
Forfeited			-			-
Unvested shares expected to vest at April 4, 2015			70,000		$	1.55
As of April 4, 2015, there was approximately $108,000 of total unrecognized compensation expense related to the restricted stock award to a non-employee.  That cost is expected to be recognized over a period of 2.9 years as of April 4, 2015.
Non-Employee Option, Stock and Restricted Stock Compensation
The Company recognized share-based compensation expense of approximately $338,000 and $50,000 in general and administrative expenses in the statement of operations for the three months ended April 4, 2015 and March 29, 2014, respectively.

Business_Segments

Business Segments	3 Months Ended
	Apr. 04, 2015
Business Segments
Business Segments	The Company has following three reportable segments.
	·           Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients to the manufacturers of consumer products in various industries including the nutritional supplement, food and beverage and animal health industries.
	·           Core standards, and contract services segment includes supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, reference materials, and related contract services.
	·           Scientific and regulatory consulting segment which consist of providing scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage potential health and regulatory risks.
	The “Other” classification includes corporate items not allocated by the Company to each reportable segment. Further, there are no intersegment sales that require elimination.  The Company evaluates performance and allocates resources based on reviewing gross margin by reportable segment.
	Three months ended			Core Standards and		Scientific and
	4-Apr-15			Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Net sales	$	2,680,341	$	2,300,043	$	280,587	$	-		$	5,260,971
	Cost of sales		1,603,176		1,573,784		156,387		-			3,333,347
	Gross profit		1,077,165		726,259		124,200		-			1,927,624
	Operating expenses:
	Sales and marketing		274,624		310,944		209		-			585,777
	General and administrative		-		-		-		2,247,931			2,247,931
	Operating expenses		274,624		310,944		209		2,247,931			2,833,708
	Operating income (loss)	$	802,541	$	415,315	$	123,991	$	(2,247,931	)	$	(906,084	)
	Three months ended			Core Standards and		Scientific and
	29-Mar-14			Contract Services		Regulatory
				segment		Consulting segment
		Ingredients						Other			Total
		segment
	Net sales	$	1,136,309	$	1,735,883	$	201,946	$	-		$	3,074,138
	Cost of sales		718,177		1,193,635		177,318		-			2,089,130
	Gross profit		418,132		542,248		24,628		-			985,008
	Operating expenses:
	Sales and marketing		239,960		212,775		11,832		-			464,567
	General and administrative		-		-		-		2,337,663			2,337,663
	Loss from investment in affiliate		-		-		-		21,543			21,543
	Operating expenses		239,960		212,775		11,832		2,359,206			2,823,773
	Operating income (loss)	$	178,172	$	329,473	$	12,796	$	(2,359,206	)	$	(1,838,765	)
	At April 4, 2015			Core Standards and		Scientific and
				Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Total assets	$	3,407,868	$	3,620,787	$	79,778	$	3,876,396		$	10,984,829
	At January 3, 2015			Core Standards and		Scientific and
				Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Total assets	$	3,757,073	$	3,220,518	$	105,711	$	4,433,545		$	11,516,847

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 04, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
	On January 31, 2015, the Company entered into a financing transaction to purchase laboratory equipment.  Under the lease terms, the Company will make monthly lease payments, including interest, of approximately $7,000 for 48 months, for a total payment of approximately $356,000.  The Company has recorded a capital lease of approximately $304,000.  The equipment will be utilized in our core standards and contract services segment.

Subsequent_Events

Subsequent Events	3 Months Ended
	Apr. 04, 2015
Subsequent Events [Abstract]
Subsequent Events	On April 16, 2015, the Board of Directors (the “Board”) appointed Jeff Baxter to serve as a member of the Board.
	Also on April 16, 2015, Mark Germain resigned from the Board.  Mr. Germain’s resignation was not as a result of any disagreements with the Company’s operations, policies or practices.  The Board approved granting Mr. Germain 125,000 shares as compensation for his services to the Company.  These shares vested immediately.  Effective April 16, 2015 upon his resignation from the Board, the Board authorized immediate vesting of Mr. Germain’s 10,000 shares of restricted stock and options to purchase 751,024 shares of common stock which were previously granted.

Significant_Accounting_Policie1

Significant Accounting Policies (Policy)	3 Months Ended
	Apr. 04, 2015
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation:  The financial statements and accompanying notes have been prepared on a consolidated basis and reflect the consolidated financial position of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated from these financial statements. The Company’s fiscal year ends on the Saturday closest to December 31.    Every fifth or sixth fiscal year, the inclusion of an extra week occurs due to the Company’s floating year-end date. The fiscal year 2014 ended on January 3, 2015 consisted of 53 weeks. The fiscal year 2015 ending on January 2, 2016 will include the normal 52 weeks.
Changes in accounting estimate	Changes in accounting principle: In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.  The amendments in this ASU require that debt issuance costs related to a debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs have not changed.  For public business entities, the amendments are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years.  Early adoption of the amendments is permitted for financial statements that have not been previously issued.
	The Company early adopted the amendments in this ASU effective as of April 4, 2015.  As of April 4, 2015 and January 3, 2015, the Company had unamortized debt issuance costs of $80,455 and $91,361, respectively.  The Company had previously presented the debt issuance costs as other noncurrent assets in its consolidated balance sheet as of January 3, 2015 in the Company’s Annual Report on Form 10-K filed with the Commission on March 19, 2015.  The early adoption has resulted in adjustments to the Company’s consolidated balance sheet as of January 3, 2015, by reclassifying the debt issuance costs as a direct deduction from the carrying amount of the debt liability.  Below are the effects of the change on the consolidated balance sheet as of January 3, 2015.
	ChromaDex Corporation and Subsidiaries
	Condensed Consolidated Balance Sheet
	3-Jan-15
		Previously		Adjustments			As Adjusted
		Reported
	Assets
	Current Assets	$	9,898,691	$	-		$	9,898,691
	Leasehold Improvements and Equipment, net		1,264,660		-			1,264,660
	Other Noncurrent Assets		444,857		(91,361	)		353,496
	Total assets	$	11,608,208	$	(91,361	)	$	11,516,847
	Liabilities and Stockholders' Equity
	Current Liabilities	$	4,980,820	$	-		$	4,980,820
	Loan payable, less current maturities, net		2,068,474		(91,361	)		1,977,113
	Capital lease obligations, less current maturities		423,015		-			423,015
	Deferred rent, less current		137,508		-			137,508
	Total liabilities		7,609,817		(91,361	)		7,518,456
	Total stockholders' equity		3,998,391		-			3,998,391
	Total liabilities and stockholders' equity	$	11,608,208	$	(91,361	)	$	11,516,847
Inventories	Inventories:  Inventories are comprised of raw materials, work-in-process and finished goods.  They are stated at the lower of cost, determined by the first-in, first-out method (FIFO) method, or market.  Labor and overhead has been added to inventory that was manufactured or characterized by the Company.  The amounts of major classes of inventory as of April 4, 2015 and January 3, 2015 are as follows:
		4-Apr-15		3-Jan-15
	Reference standards	$	1,718,313	$	1,760,305
	Bulk ingredients		1,956,383		2,298,036
			3,674,696		4,058,341
	Less valuation allowance		443,000		324,000
		$	3,231,696	$	3,734,341

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	3 Months Ended
	Apr. 04, 2015
Accounting Policies [Abstract]
Restatement	ChromaDex Corporation and Subsidiaries
	Condensed Consolidated Balance Sheet
	3-Jan-15
		Previously		Adjustments			As Adjusted
		Reported
	Assets
	Current Assets	$	9,898,691	$	-		$	9,898,691
	Leasehold Improvements and Equipment, net		1,264,660		-			1,264,660
	Other Noncurrent Assets		444,857		(91,361	)		353,496
	Total assets	$	11,608,208	$	(91,361	)	$	11,516,847
	Liabilities and Stockholders' Equity
	Current Liabilities	$	4,980,820	$	-		$	4,980,820
	Loan payable, less current maturities, net		2,068,474		(91,361	)		1,977,113
	Capital lease obligations, less current maturities		423,015		-			423,015
	Deferred rent, less current		137,508		-			137,508
	Total liabilities		7,609,817		(91,361	)		7,518,456
	Total stockholders' equity		3,998,391		-			3,998,391
	Total liabilities and stockholders' equity	$	11,608,208	$	(91,361	)	$	11,516,847
Inventories
		4-Apr-15		3-Jan-15
	Reference standards	$	1,718,313	$	1,760,305
	Bulk ingredients		1,956,383		2,298,036
			3,674,696		4,058,341
	Less valuation allowance		443,000		324,000
		$	3,231,696	$	3,734,341

Loss_Per_Share_Applicable_to_C1

Loss Per Share Applicable to Common Stockholders (Tables)	3 Months Ended
	Apr. 04, 2015
Loss Per Share Applicable To Common Stockholders Tables
Loss per share amounts applicable to common stockholders		Three Months Ended
		April 4,			March 29,
		2015			2014
	Net loss	$	(1,025,515	)	$	(1,848,016	)
	Basic and diluted loss per common share	$	(0.01	)	$	(0.02	)
	Weighted average common shares outstanding (1):		107,198,597			106,076,361
	Potentially dilutive securities (2):
	Stock options		14,146,969			13,326,655
	Warrants		469,020			-
	Convertible Debt		773,395			-

Leasehold_Improvements_and_Equ1

Leasehold Improvements and Equipment (Tables)	3 Months Ended
	Apr. 04, 2015
Leasehold Improvements And Equipment
Leasehold improvements and equipment		April 4,		3-Jan-15
		2015
	Laboratory equipment	$	3,514,733	$	3,151,748
	Leasehold improvements		495,240		495,240
	Computer equipment		333,567		329,737
	Furniture and fixtures		13,039		13,039
	Office equipment		7,877		7,877
	Construction in progress		28,737		68,141
			4,393,193		4,065,782
	Less accumulated depreciation		2,813,199		2,801,122
		$	1,579,994	$	1,264,660

Loan_Payable_Tables

Loan Payable (Tables)	3 Months Ended
	Apr. 04, 2015
Debt Disclosure [Abstract]
Loan payable	Principal amount payable for following years ending December
	2015	$	223,358
	2016		867,247
	2017		1,035,995
	2018		373,400
	Total principal payments		2,500,000
	Accrued end of term charge		20,425
	Total loan payable		2,520,425
	Less unamortized debt issuance costs and debt discount		273,006
	Less current portion		452,672
	Loan payable – long term	$	1,794,747

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	3 Months Ended
	Apr. 04, 2015
Share-based Compensation Tables
Weighted average assumptions of stock options granted	Three Months Ended April 4, 2015
	Expected volatility	75%
	Expected dividends	0.00%
	Expected term	6.1 years
	Risk-free rate	1.68%
Service Period Based Stock Options						Weighted Average				Aggregate
										Intrinsic
			Number of			Exercise		Remaining		Value
			Shares			Price		Contractual
								Term
	Outstanding at January 3, 2015			12,723,601		$	1.13		7
	Options Granted			185,000			1.29		10
	Options Classification from Employee to Non-Employee			(451,738	)		0.88
	Options Exercised			-			-
	Options Forfeited			(12,083	)		1.14
	Outstanding at April 4, 2015			12,444,780		$	1.14		6.75	$	5,237,000
	Exercisable at April 4, 2015			9,608,011		$	1.14		6.21	$	3,981,000
Restricted stock awards granted to employees			Shares			Weighted Average
						Award-Date
						Fair Value
	Unvested shares at January 3, 2015			1,590,000		$	1.18
	Granted			-			-
	Vested			(500,000	)		1.41
	Forfeited			-			-
	Unvested shares at April 4, 2015			1,090,000		$	1.08
	Expected to Vest as of April 4, 2015			1,090,000		$	1.08
Non-Employee stock options						Weighted Average
			Number of			Exercise		Remaining		Aggregate
			Shares			Price		Contractual		Intrinsic
								Term		Value
	Outstanding at January 3, 2015			1,050,451		$	1.35		5.46
	Options Granted			-			-
	Options Classification from Employee to Non-Employee			451,738			0.88
	Options Exercised			-			-
	Options Forfeited			-			-
	Outstanding at April 4, 2015			1,502,189		$	1.21		6.07	$	506,000
	Exercisable at April 4, 2015			1,434,689		$	1.21		5.91	$	485,000
Restricted stock awards granted to non-employees						Weighted Average
			Shares			Fair Value
	Unvested shares at January 3, 2015			76,000		$	0.9
	Granted			-			-
	Vested			(6,000	)		1.23
	Forfeited			-			-
	Unvested shares expected to vest at April 4, 2015			70,000		$	1.55

Business_Segments_Tables

Business Segments (Tables)	3 Months Ended
	Apr. 04, 2015
Business Segments Tables
Business Segmentation
	Three months ended			Core Standards and		Scientific and
	4-Apr-15			Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Net sales	$	2,680,341	$	2,300,043	$	280,587	$	-		$	5,260,971
	Cost of sales		1,603,176		1,573,784		156,387		-			3,333,347
	Gross profit		1,077,165		726,259		124,200		-			1,927,624
	Operating expenses:
	Sales and marketing		274,624		310,944		209		-			585,777
	General and administrative		-		-		-		2,247,931			2,247,931
	Operating expenses		274,624		310,944		209		2,247,931			2,833,708
	Operating income (loss)	$	802,541	$	415,315	$	123,991	$	(2,247,931	)	$	(906,084	)
	Three months ended			Core Standards and		Scientific and
	29-Mar-14			Contract Services		Regulatory
				segment		Consulting segment
		Ingredients						Other			Total
		segment
	Net sales	$	1,136,309	$	1,735,883	$	201,946	$	-		$	3,074,138
	Cost of sales		718,177		1,193,635		177,318		-			2,089,130
	Gross profit		418,132		542,248		24,628		-			985,008
	Operating expenses:
	Sales and marketing		239,960		212,775		11,832		-			464,567
	General and administrative		-		-		-		2,337,663			2,337,663
	Loss from investment in affiliate		-		-		-		21,543			21,543
	Operating expenses		239,960		212,775		11,832		2,359,206			2,823,773
	Operating income (loss)	$	178,172	$	329,473	$	12,796	$	(2,359,206	)	$	(1,838,765	)
	At April 4, 2015			Core Standards and		Scientific and
				Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Total assets	$	3,407,868	$	3,620,787	$	79,778	$	3,876,396		$	10,984,829
	At January 3, 2015			Core Standards and		Scientific and
				Contract Services		Regulatory
		Ingredients		segment		Consulting segment		Other			Total
		segment
	Total assets	$	3,757,073	$	3,220,518	$	105,711	$	4,433,545		$	11,516,847

Nature_of_Business_and_Liquidi1

Nature of Business and Liquidity (Details Narrative) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014	Jan. 03, 2015
Liquidity
Operating (loss)	($906,084)	($1,838,765)
Net (loss)	-1,025,515	-1,848,016
Cash and cash equivalents	3,215,839	1,924,538	3,964,750
Term loan, amount available for future draw	$2,500,000

Significant_Accounting_Policie3

Significant Accounting Policies (Details) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Current assets	$9,056,338	$9,898,691
Leasehold Improvements and Equipment, net	1,579,994	1,264,660
Other noncurrent assets	348,497	353,496
Total assets	10,984,829	11,516,847
Current liabilities	4,771,908	4,980,820
Loan payable, less current maturities, net	1,794,747	1,977,113
Capital lease obligations, less current maturities	610,738	423,015
Deferred rent, less current	118,651	137,508
Total liabilities	7,296,044	7,518,456
Total stockholders' equity	3,688,785	3,998,391
Total liabilities and stockholders' equity	10,984,829	11,516,847
Scenario, Previously Reported [Member]
Current assets		9,898,691
Leasehold Improvements and Equipment, net		1,264,660
Other noncurrent assets		44,857
Total assets		11,608,208
Current liabilities		1,980,820
Loan payable, less current maturities, net		2,068,474
Capital lease obligations, less current maturities		423,015
Deferred rent, less current		137,508
Total liabilities		7,609,817
Total stockholders' equity		3,998,391
Total liabilities and stockholders' equity		11,608,208
Restatement Adjustment [Member]
Current assets
Leasehold Improvements and Equipment, net
Other noncurrent assets		-91,361
Total assets		-91,361
Current liabilities
Loan payable, less current maturities, net		-91,361
Capital lease obligations, less current maturities
Deferred rent, less current
Total liabilities		-91,361
Total stockholders' equity
Total liabilities and stockholders' equity		($91,361)

Significant_Accounting_Policie4

Significant Accounting Policies (Details 1) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Inventories
Reference standards	$1,718,313	$1,760,305
Bulk ingredients	1,956,383	2,298,036
Inventory-gross	3,674,696	4,058,341
Less valuation allowance	443,000	324,000
Inventory-net	$3,231,696	$3,734,341

Significant_Accounting_Policie5

Significant Accounting Policies (Details Narrative) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Significant Accounting Policies Details Narrative
Unamortized debt issuance costs	$80,455	$91,361

Loss_Per_Share_Applicable_to_C2

Loss Per Share Applicable to Common Stockholders (Details) (USD $)	3 Months Ended
	Apr. 04, 2015		Mar. 29, 2014
Net loss	($1,025,515)		($1,848,016)
Earnings per share
Basic and diluted loss per common share	($0.01)		($0.02)
Weighted average common shares outstanding	107,198,597	[1]	106,076,361	[1]
Stock Option [Member]
Earnings per share
Potentially dilutive securities	14,146,969	[2]	13,326,655	[2]
Warrant [Member]
Earnings per share
Potentially dilutive securities	469,020	[2]		[2]
Convertible Debt [Member]
Earnings per share
Potentially dilutive securities	773,395	[2]		[2]
[1]	Includes 1,554,088 and 1,542,088 weighted average nonvested shares of restricted stock for the three months ended April 4, 2015 and March 29, 2014, respectively, which are participating securities that feature voting and dividend rights.
[2]	Excluded from the computation of loss per share as their impact is antidilutive.

Loss_Per_Share_Applicable_to_C3

Loss Per Share Applicable to Common Stockholders (Details Narrative)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014
Loss Per Share Applicable To Common Stockholders Details Narrative
Weighted average nonvested shares of restricted stock	1,554,088	1,542,088

Leasehold_Improvements_and_Equ2

Leasehold Improvements and Equipment (Details) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Leasehold improvements and equipment
Laboratory equipment	$3,514,733	$3,151,748
Leasehold improvements	495,240	495,240
Computer equipment	333,567	329,737
Furniture and fixtures	13,039	13,039
Office equipment	7,877	7,877
Construction in progress	28,737	68,141
Leasehold improvements and equipment, gross	4,393,193	4,065,782
Less accumulated depreciation	2,813,199	2,801,122
Leasehold improvements and equipment, total	$1,579,994	$1,264,660

Leasehold_Improvements_and_Equ3

Leasehold Improvements and Equipment (Details Narrative) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014
Leasehold Improvements And Equipment Details Narrative
Depreciation expense on leasehold improvements and equipment	$66,902	$50,919

Loan_Payable_Loan_payable_Deta

Loan Payable - Loan payable (Details) (USD $)	Apr. 04, 2015	Jan. 03, 2015
Principal amount payable for following years ending December
2015	$223,358
2016	867,247
2017	1,035,995
2018	373,400
Total principal payments	2,500,000
Accrued end of term charge	20,425
Total loan payable	2,520,425
Less unamortized debt issuance costs and debt discount	273,006
Less current portion	452,672	223,358
Loan payable b long term	$1,794,747	$1,977,113

Loan_Payable_Details_Narrative

Loan Payable (Details Narrative) (USD $)	3 Months Ended
	Apr. 04, 2015
Debt Disclosure [Abstract]
Interest expenses	$106,000

ShareBased_Compensation_Assump

Share-Based Compensation - Assumptions (Details)	3 Months Ended
	Apr. 04, 2015
Share-based Compensation - Assumptions Details
Expected volatility	75.00%
Expected dividends	0.00%
Expected term	6 years 1 month 6 days
Risk-free rate	1.68%

ShareBased_Compensation_Servic

Share-Based Compensation - Service Based (Details 1) (USD $)	3 Months Ended
	Apr. 04, 2015
Number of Shares
Outstanding at Beginning of Period	12,723,601
Options Granted	185,000
Options Classification from Employee to Non-Employee	($451,738)
Options Exercised
Options Forfeited	-12,083
Outstanding at End of Period	12,444,780
Exercisable at End of Period	9,608,011
Weighted Average Exercise Price
Outstanding at Beginning of Period	$1.13
Options Granted	$1.29
Options Classification from Employee to Non-Employee	$0.88
Options Exercised
Options Forfeited	$1.14
Outstanding at End of Period	$1.14
Exercisable at End of Period	$1.14
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	7 years
Options Granted	10 years
Outstanding at End of Period	6 years 9 months
Exercisable at End of Period	6 years 2 months 15 days
Aggregate Intrinsic Value
Outstanding at End of Period	5,237,000
Exercisable at End of Period	$3,981,000

ShareBased_Compensation_Employ

Share-Based Compensation - Employees - Restricted Stock (Details 2) (Restricted Stock [Member], USD $)	3 Months Ended
	Apr. 04, 2015
Restricted Stock [Member]
Summary of activity of restricted stock awards granted to employees- Shares
Unvested shares at Beginning of Period	1,590,000
Granted
Vested	-500,000
Forfeited
Unvested shares at End of Period	1,090,000
Expected to Vest as of End of Period	1,090,000
Weighted Average Award-Date Fair Value
Unvested shares at Beginning of Period	$1.18
Granted
Vested	$1.41
Forfeited
Unvested shares at End of Period	$1.08
Expected to Vest as of End of Period	$1.08

ShareBased_Compensation_NonEmp

Share-Based Compensation - NonEmployee (Details 3) (USD $)	3 Months Ended
	Apr. 04, 2015
Non-Employee Share-Based Compensation- Options
Outstanding at Beginning of Period	1,050,451
Options Granted
Options Classification from Employee to Non-Employee	451,738
Options Exercised
Options Forfeited
Outstanding at End of Period	1,502,189
Exercisable at End of Period	1,434,689
Weighted Average Exercise Price
Outstanding at Beginning of Period	$1.35
Options Granted
Options Classification from Employee to Non-Employee	$0.88
Options Exercised
Options Forfeited
Outstanding at End of Period	$1.21
Exercisable at End of Period	$1.21
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	5 years 5 months 15 days
Outstanding at End of Period	6 years 25 days
Exercisable at End of Period	5 years 10 months 27 days
Aggregate Intrinsic Value
Outstanding at End of Period	$506,000
Exercisable at End of Period	$485,000

ShareBased_Compensation_Restri

Share-Based Compensation - Restricted Stock (Details 4) (NonEmployee Restricted Stock [Member], USD $)	3 Months Ended
	Apr. 04, 2015
NonEmployee Restricted Stock [Member]
Unvested shares at Beginning of Period	76,000
Granted
Vested	-6,000
Forfeited
Unvested shares expected to vest at End of Period	70,000
Weighted Average Award-Date Fair Value
Unvested shares at Beginning of Period	$0.90
Granted
Vested	$1.23
Forfeited
Unvested shares at End of Period	$1.55

ShareBased_Compensation_Detail

Share-Based Compensation (Details Narrative) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014
Options issued
Employee Comp [Member]
Weighted average fair value of options granted	$0.85
Closing stock price	$1.55
Unrecognized stock option expense	$1,434,000
Period of stock option expense expected to be recognized over	2 years 4 months 20 days
General and administrative expenses	378,000	950,000
NonEmployee Comp [Member]
Closing stock price	$1.55
Unrecognized stock option expense	67,000
Period of stock option expense expected to be recognized over	1 year 5 months 8 days
General and administrative expenses	338,000	50,000
Common stock shares awarded, shares	350,000
Common stock shares awarded fully vested, shares	210,000
Common stock shares awarded forfeitable, shares	140,000
Common stock shares awarded, vested fair value	180,600
Common stock shares awarded, period of expense to be recognized	2 months
Unrecognized expense related to stock awards	98,000
Unrecognized expense related to restricted stock awards	108,000
Restricted Stock award, period of expense expected to be recognized over	2 years 10 months 24 days
Fair value of vested restricted stock awards	$7,000

Business_Segments_Details

Business Segments (Details) (USD $)	3 Months Ended
	Apr. 04, 2015	Mar. 29, 2014	Jan. 03, 2015
Net sales	$5,260,971	$3,074,138
Cost of sales	3,333,347	2,089,130
Gross profit	1,927,624	985,008
Sales and marketing	585,777	464,567
General and administrative	2,247,931	2,337,663
Loss from investment in affiliate		21,543
Operating expenses	2,833,708	2,823,773
Operating income (loss)	-906,084	-1,838,765
Assets	10,984,829		11,516,847
CoreStandardsContractServices [Member]
Net sales	2,680,341	1,136,309
Cost of sales	1,603,176	718,177
Gross profit	1,077,165	418,132
Sales and marketing	274,624	239,960
General and administrative
Loss from investment in affiliate
Operating expenses	274,624	239,960
Operating income (loss)	802,541	178,172
Assets	3,407,868		3,757,073
Ingredients Segment [Member]
Net sales	2,300,043	1,735,883
Cost of sales	1,573,784	1,193,635
Gross profit	726,259	542,248
Sales and marketing	310,944	212,775
General and administrative
Loss from investment in affiliate
Operating expenses	310,944	212,775
Operating income (loss)	415,315	329,473
Assets	3,620,787		3,220,518
Regulatory Consulting [Member]
Net sales	280,587	201,946
Cost of sales	156,387	177,318
Gross profit	124,200	24,628
Sales and marketing	209	11,832
General and administrative
Loss from investment in affiliate
Operating expenses	209	11,832
Operating income (loss)	123,991	12,796
Assets	79,778		105,711
Other Segment [Member]
Net sales
Cost of sales
Gross profit
Sales and marketing
General and administrative	2,247,931	2,337,663
Loss from investment in affiliate		21,543
Operating expenses	2,247,931	2,359,206
Operating income (loss)	-2,247,931	-2,359,206
Assets	$3,876,396		$4,433,545

Commitments_and_Contingencies_

Commitments and Contingencies (Details Narrative) (USD $)	3 Months Ended
	Apr. 04, 2015
Commitments And Contingencies Details Narrative
Monthly lease payment	$7,000
Capital lease term	48 months
Capital lease future payments	356,000
Capital lease	$304,000

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative)	1 Months Ended
	13-May-15
Subsequent Events [Abstract]
Share based compensation, shares	125,000
Restricted stock vested during period	10,000
Options vested during period	751,024